Difficulties in Robotic-Assisted Nerve-Sparing Radical Prostatectomy

Serum prostate-specific antigen (PSA) screening, coupled with a rising incidence of needle biopsies in asymptomatic men, have all contributed to prostate cancer becoming the most common cancer in men in the United States1,2 and other parts of the world.3 With increasing evidence of improved long-term survival and progression-free outcomes,4–7 radical prostatectomy has become increasingly popular as the treatment of first choice for organ-confined disease.